scispace - formally typeset
E

Eileen White

Researcher at Rutgers University

Publications -  241
Citations -  51179

Eileen White is an academic researcher from Rutgers University. The author has contributed to research in topics: Autophagy & Programmed cell death. The author has an hindex of 95, co-authored 226 publications receiving 44992 citations. Previous affiliations of Eileen White include University of Tokyo & University of Medicine and Dentistry of New Jersey.

Papers
More filters
Journal ArticleDOI

An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy

Mickaël Michaud, +5 more
- 17 Jul 2014 - 
TL;DR: It appears that the success of chemotherapy against “spontaneous,” genetically induced cancers is governed by the same rules as those applicable to transplantable tumors.
Journal ArticleDOI

Apoptosis-Inducing Galactolipids from a Cultured Marine Diatom, Phaeodactylum tricornutum

Eric H. Andrianasolo, +5 more
- 21 Jun 2008 - 
TL;DR: The first report of apoptosis induction by galactolipids is reported, using genetically engineered mammalian cell lines with differential, defined capacities for apoptosis.
Journal Article

Interleukin 1 beta converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis.

Peter Sabbatini, +4 more
- 01 Jun 1997 - 
TL;DR: Results indicate that all apoptotic pathways downstream of p53-mediated transcription converge upon the activation of ICE-like proteases.
Journal ArticleDOI

Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity

Junjiang Fu, +9 more
- 13 Mar 2009 - 
TL;DR: The identification of a novel AR coactivator, deleted in breast cancer 1 (DBC1), through a biochemical approach is reported, which interacts with AR in a ligand-stimulated manner and facilitates AR transcriptional activation in transfected cells as well as in Xenopus oocytes.
Journal ArticleDOI

Effect of dual inhibition of apoptosis and autophagy in prostate cancer.

Ahamed Saleem, +8 more
- 01 Sep 2012 - 
TL;DR: Targeting multiple anti‐apoptotic proteins is now possible with the small molecule BH3 domain mimetics such as ABT‐737, and it is hypothesized that hydroxychloroquine (HCQ), an anti‐malarial drug that inhibits autophagy, will increase cytotoxicity of ABT-737.